Blog
RSS FeedPosted by Michael Wonder on 29 Aug 2016
CADTH recommends against the reimbursement of Egrifta (tesamorelin acetate)
24 August 2016 - CADTH is not convinced that Egrifta should be reimbursed in Canada. ...
Posted by Michael Wonder on 29 Aug 2016
CADTH recommends the reimbursement of Descovy (emtricitabine with tenofovir alafenamide fumarate)
24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...
Posted by Michael Wonder on 28 Aug 2016
Cancer campaigner and melanoma patient Jeffrey Paterson dies aged 23
28 August 2016 - Young melanoma patient Jeffrey Paterson helped to win the campaign for Government funding of Keytruda, but didn't ...
Posted by Michael Wonder on 28 Aug 2016
CADTH recommends reimbursement of secukinumab (Cosentyx) for ankylosing spondylitis
23 August 2016 - CADTH publishes second outcome for Cosentyx this month. ...
Posted by Michael Wonder on 28 Aug 2016
CADTH recommends reimbursement of Truvada for PrEP
24 August 2016 - The recommendation comes with conditions. ...
Posted by Michael Wonder on 26 Aug 2016
NICE backs non-surgical option for fibroids
26 August 2016 - Women with uterine fibroids stand to gain routine access to a non-surgical treatment on the NHS for ...
Posted by Michael Wonder on 26 Aug 2016
New Brunswick includes Lemtrada (alemtuzumab) on provincial drug program for eligible patients
25 August 2016 - Unique treatment delivered in only two cycles one year apart. ...
Posted by Michael Wonder on 25 Aug 2016
CADTH recommends the reimbursement of secukinumab (Cosentyx) for psoriatic arthritis
23 August 2016 - CADTH has issued a final recommendation on the reimbursement of secukinumab (Cosentyx) for patients with psoriatic ...
Posted by Michael Wonder on 25 Aug 2016
Submissions to the review of pharmacy remuneration and regulation
25 August 2016 - Public submissions to the review have been made public. ...
Posted by Michael Wonder on 25 Aug 2016
NICE recommends Servier's Lonsurf (trifluridine with tipiracil hydrochloride)
24 August 2016 - New treatment for patients with advanced colorectal cancer. ...
Posted by Michael Wonder on 24 Aug 2016
Insights from the agenda for the PBAC November 2016 meeting
24 August 2016 - Some important insights can be gleaned from the agenda. ...
Posted by Michael Wonder on 24 Aug 2016
Summary of the agenda for the PBAC November 2016 meeting
24 August 2016 - The PBAC will consider 66 submissions (34 major & 32 minor) at its next scheduled meeting in ...
Posted by Michael Wonder on 24 Aug 2016
NICE issues draft guidance on the use of Eylea (afilbercept)
24 August 2016 - NICE has issued draft final guidance on the use of Bayer's Eylea (aflibercept) on the NHS. ...
Posted by Michael Wonder on 24 Aug 2016
NICE approves new cancer drugs for routine NHS use
24 August 2016 - Two cancer treatments, previously only available to patients through the Cancer Drugs Fund, will now be routinely ...
Posted by Michael Wonder on 23 Aug 2016
Brisbane sees 30% drop in HIV infection over 5 year period; HIV medicine Truvada still not on PBS
23 August 2016 - The combination HIV medicines that has led to a significant drop in the number of HIV cases ...